News

What BIO Europe 2025 Revealed About the Future of Phase I and II Oncology Trials

At BIO Europe 2025, we spoke with oncology…
Read Article

BIO Europe 2025 in Vienna

Medelis, a specialty oncology CRO focused on early-phase…
Read Article

BIO 2025 Boston: Key Takeaways for Clinical Development Teams

After four intensive days in Boston, it's clear…
Read Article

ASCO 2025 — Let’s Talk About What’s Next in Oncology

Medelis will be attending ASCO 2025 in Chicago…
Read Article

Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

The 2024 ASCO Annual Meeting presents an unmissable…
Read Article

FDA’s New Guidance on Diversity in Clinical Trials: New Challenges for Patient Recruitment

The U.S. Food and Drug Administration (FDA) recently…
Read Article

The Poster Child of International Clinical Trial Success: Legend Biotech’s Carvykti/Cilta-cel Immunotherapy Achieves FDA Approval

With many in biotech and pharma in China…
Read Article

Chinese Clinical Trial Data – Still Relevant to the FDA

For Chinese companies bringing oncology drugs to the…
Read Article

FDA Guidance on Conduct of Clinical Trials During COVID-19

These are challenging times, as the world grapples…
Read Article